How Can We Improve the Current Stent Technology? - Michael Joner, MD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - New Stent Platforms and Local Drug Delivery

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

How Can We Improve the Current Stent Technology? presented by Michael Joner, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: New Stent Platforms and Local Drug Delivery

Track: Technology & Innovation

Learning Objectives

  • Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview
Utility of Direct Adventitial Delivery of Dexamethasone to Prevent Restenosis - DANCE and LIMBO Studies - George Adams, MD, MHS
Local Drug Delivery Primer for PAD - Sahil Parikh, MD, FSCAI
Micro-engineered Grooved Stent Surfaces and Beyond: Technology Description and Preliminary Data - Juan Granada, MD
How Can We Improve the Current Stent Technology? - Michael Joner, MD
Loading Simple Education